Langerhans cell histiocytosis of the urinary bladder in a patient with bladder cancer previously treated with intravesical Bacillus Calmette-Guerin therapy

被引:6
|
作者
Numakura, Satoe [1 ]
Morikawa, Teppei [1 ]
Ushiku, Tetsuo [1 ]
Toyoshima, Toyoaki [2 ]
Fukayama, Masashi [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan
[2] Yuai Mem Hosp, Dept Urol, Koga, Japan
关键词
Eosinophilic granuloma; Histiocytosis X; Immunohistochemistry; Immunotherapy; Pathological diagnosis; ERDHEIM-CHESTER DISEASE; BRAF V600E MUTATION; EOSINOPHILIC CYSTITIS; MITOMYCIN-C; CARCINOMA; VEMURAFENIB; DIAGNOSIS; GRANULOMA; MELANOMA; TUMOR;
D O I
10.1016/j.prp.2013.11.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report an extremely rare case of Langerhans cell histiocytosis (LCH) of the urinary bladder. A 68-year-old man presented with gross hematuria. Cystoscopy showed multiple papillary tumors in the urinary bladder, and transurethral resection was performed. Pathological diagnosis was high-grade papillary urothelial carcinoma with lamina propria invasion. The patient received six treatments with intravesical Bacillus Calmette-Guerin (BCG) therapy. Seven months after surgery, follow-up cystoscopy showed three elevated lesions in the urinary bladder, two of which were identified histologically as recurrent urothelial carcinoma. Microscopic examination of the lesion at the anterior wall revealed diffuse infiltration of medium to large histiocytoid cells in the lamina propria, many of which had distorted nuclei and nuclear grooves. Dense eosinophilic infiltration was also observed. Immunohistochemically, the histiocytoid cells were diffusely positive for S-100 and CD1a, but negative for cytokeratin AE1/AE3 and melanosome-associated antigen recognized by HMB-45. Based on the histological and immunohistochemical features, we diagnosed the lesion as LCH of the urinary bladder. There was no evidence of recurrence of either bladder cancer or LCH after an 18-month follow-up. To avoid misdiagnosis, urologists and pathologists should be aware that LCH may develop in the urinary bladder after intravesical BCG therapy for bladder cancer. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:123 / 126
页数:4
相关论文
共 50 条
  • [31] Bacillus Calmette-Guerin (BCG) Brazilian Backstage in Bladder Cancer
    Korkes, Fernando
    Timoteo, Frederico
    Ferrari, Karen Linares
    Reis, Leonardo Oliveira
    INTERNATIONAL BRAZ J UROL, 2021, 47 (02): : 232 - 236
  • [32] Mycotic Aortic Aneurysm and Infected Aortic Graft After Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer
    Lareyre, Fabien
    Reverso-Meinietti, Julie
    Carboni, Joseph
    Gaudart, Alice
    Hassen-Khodja, Reda
    Raffort, Juliette
    VASCULAR AND ENDOVASCULAR SURGERY, 2019, 53 (01) : 86 - 91
  • [33] T2a transitional cell carcinoma of the bladder: Longterm experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin
    Volkmer, BG
    Gschwend, JE
    Maier, SH
    Seidl-Schlick, EM
    Bach, D
    Romics, I
    JOURNAL OF UROLOGY, 2003, 169 (03) : 931 - 934
  • [34] Reiter?s syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: Case report
    Alsulami, Hajar Aown Allah
    Al-Nashiwaty, Omar
    Khalifa, Mahassen Aly
    Syed, Nazar Ulla
    Ahmed, Noha
    Almuthree, Souad
    IDCASES, 2023, 31
  • [35] Combined Thermo-Chemotherapy for Recurrent Bladder Cancer After Bacillus Calmette-Guerin
    Nativ, Ofer
    Witjes, J. Alfred
    Hendricksen, Kees
    Cohen, Michael
    Kedar, Daniel
    Sidi, Ami
    Colombo, Renzo
    Leibovitch, Ilan
    JOURNAL OF UROLOGY, 2009, 182 (04) : 1313 - 1317
  • [36] A Prospective Comparative Study of Intravesical Bacillus Calmette-Guerin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
    Sengiku, Atsushi
    Ito, Masaaki
    Miyazaki, Yu
    Sawazaki, Harutake
    Takahashi, Takeshi
    Ogura, Keiji
    JOURNAL OF UROLOGY, 2013, 190 (01) : 50 - 54
  • [37] Intravesical bacillus Calmette-Guerin therapy after second transurethral resection for primary T1 bladder cancer
    Baba, Masato
    Kageyama, Susumu
    Yoshida, Tetsuya
    Fujiwara, Ryo
    Kim, Chul Jang
    Takimoto, Keita
    Nagasawa, Masayuki
    Soga, Hiroki
    Nagatani, Yukihiro
    Nishikawa, Zenkai
    Kawauchi, Akihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (05) : 951 - 956
  • [38] The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Sfakianos, John P.
    Kim, Philip H.
    Hakimi, A. Ari
    Herr, Harry W.
    JOURNAL OF UROLOGY, 2014, 191 (02) : 341 - 345
  • [39] The effect of lubricants on viability of bacillus Calmette-Guerin for intravesical immunotherapy against bladder carcinoma
    Bohle, A
    RuschGerdes, S
    Ulmer, AJ
    Braasch, H
    Jocham, D
    JOURNAL OF UROLOGY, 1996, 155 (06) : 1892 - 1896
  • [40] THE EFFECT OF INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY ON THE UPPER URINARY-TRACT
    MUKAMEL, E
    VILKOVSKY, E
    HADAR, H
    ENGELSTEIN, D
    NUSSBAUM, B
    SERVADIO, C
    JOURNAL OF UROLOGY, 1991, 146 (04) : 980 - 981